Skip to main content

Wisdom

A Tribute to Daniel L. Kastner, MD, PhD (1951–2026) The rheumatology, genetics and NIH communities mourn for Dr. Daniel L. Kastner, who died on July 28, 2026, in Bethesda, Maryland, at age 74. https://t.co/Qti4Nay6NX https://t.co/gjmY7G4XAc
Dr. John Cush @RheumNow( View Tweet )
JAMA Review of Hip Fracture The July 16th edition of JAMA reviews the highly prevalent problem of hip fractures - a major global health burden: 14.2 million occur worldwide annually (280,000 in the US), with global incidence higher in women (833.9/100,000) than men https://t.co/KBUovkYPB1
Dr. John Cush @RheumNow( View Tweet )

Top 20 Best Rheumatology Hospitals

U.S. News & World Report has published its Best Hospitals for 2026-2027, listing the best among many specialties, including rheumatology.  Each year U.S. News Best Hospitals ranked hospitals in the U.S. in 14 adult specialties and for the 9th year in a row, Johns Hopkins Hospital in

Read Article

A Tribute to Daniel L. Kastner, MD, PhD (1951–2026)

The rheumatology, genetics and NIH communities mourn for Dr. Daniel L. Kastner, who died on July 28, 2026, in Bethesda, Maryland, at age 74. The following are declarations, tributes, and memories dedicated to this mensch of a man, titan of science, memorable mentor and humble physician.

Read Article
Medscape asked medical authors (panel of experts), including Roach, Epstein, and several literary medical professionals — this question: What’s a book every clinician should read? Here's an interesting read list for some of you! (I loved "Stiff" by Mary Roach; its about https://t.co/L5NSHjPKwA
Dr. John Cush @RheumNow( View Tweet )
Social Media (SM) for Health Information by US (sample 7278 adults) - SM use reported by 88% (representing ~ 228 million). ~22% adults made health decisions based on SM, despite almost 78% reporting distrust of SM. Lower SM use in older, rural, less educated. https://t.co/uYYzBvckFu
Dr. John Cush @RheumNow( View Tweet )

Methotrexate Safety Tips (7.31.2026)

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.

Read Article
Coding: ICD-10 Code M45.7 describes ankylosing spondylitis of the lumbosacral region, a billable ICD-10-CM diagnosis code valid for FY2026. M45.7 became effective October 1, 2025 and belongs to the M45 parent category covering ankylosing spondylitis by anatomical site. https://t.co/jBmoD0CVps
Dr. John Cush @RheumNow( View Tweet )

Swimming Reduces Disability from Low Back Pain

EurekAlert!

Swimming is commonly recommended for patients with chronic low back pain. Yet, there is little trial data investigating swimming. An Australian study has shown for the first time that a program of swimming can be clinically effective in reducing disability from chronic low back pain

Read Article

Expert Perspective on Calcium Pyrophosphate Deposition Disease

A recent perspective by Tedeschi tackles many unresolved issues around CPPD diagnosis, classification, and management, including the lack of clinical trials or FDA approved treatments.

Read Article

ACP Position Paper on Dietary Supplements

More than half of U.S. adults use dietary supplements, yet only a quarter use supplements recommended by a healthcare professional, and current law lets supplements reach the market with no premarket safety evaluation, unlike drugs or food additives. The paper notes that under DSHEA, dietary

Read Article

Saliva and Uric Acid Testing

A recent report from China reaffirms the potential utility of salivary uric acid (UA) testing  delivers smartphone-guided, enzyme-free gout screening at home for pennies per test.

Read Article

Gout Cavalcade (7.10.2026)

Dr. Jack Cush reviews the news, journal articles and regulatory decisions from the past week. July is Gout: More than Flares month.

Read Article
Challenges in Gout Diagnosis Dr. Angelo Gaffo in Birmingham, AL discusses the challenges in diagnosing gout. Presented as part of RheumNow's "Gout: More than Flares" campaign during the month of July 2026. https://t.co/LmTj7cvBGT https://t.co/VRVCrAo2TT
Dr. John Cush @RheumNow( View Tweet )

Problems with treatment adherence in the management of gout

Compared to common medical conditions such as hypertension, type 2 diabetes, hyperlipidemia or osteoporosis, where the reported drug adherence rates are between 50% to 70%, the drug adherence for gout is 37%.

Read Article

Brenda McShan: The Creative Heart of RheumNow

A pivotal member of the RheumNow family, Brenda McShan, will be retiring with honors.

Brenda has been RheumNow's graphic artist since we began in 2014. She has well-earned her retirement, and leaves behind a decade of great work, dedication and exceptional graphics.   RheumNow's

Read Article

No Fetal Risks with First Trimester NSAID Use

PLoS Medicine has published a population-based retrospective cohort study from the Southern Israeli Pregnancy Registry (siPREG) project showing that 1st trimester exposure to NSAIDs was not associated with major congenital malformatoin (MCM) risk. 

Pain management during pregnancy

Read Article

JAMA Review on Low Back Pain

A comprehensive JAMA review synthesizes current evidence on the epidemiology, pathophysiology, clinical evaluation, and treatment of nonspecific low back pain, drawing on 108 publications identified from a PubMed search (2005–2026) and the most recent guidelines from the WHO, ACP, and NICE.

Read Article
This is a great WISE read for yound doctors - from the great WISE Dr. Adam Cifu -- Advice for Internship https://t.co/BUtXzJxQxQ

Dr. John Cush @RheumNow( View Tweet )

"When you make the choice to avoid becoming the most experienced person in a room (whatever room you’re in), you’re making a bet about the future. " - Seth Godin https://t.co/oWtDNWeoND https://t.co/2dpiFRGaxZ
Dr. John Cush @RheumNow( View Tweet )

Do You Zoster Vaccinate? (6.19.2026)

Dr. Jack Cush reviews the news, journal reports and best ways to review EULAR 2026.

Read Article
Digital Patient Education in RA Dr. Bella Mehta reviews abstract OP005-HPR presented in London at EULAR 2026 https://t.co/Wj8omKJTNx. https://t.co/h13p54BAHs
Dr. John Cush @RheumNow( View Tweet )
#EULAR2026 Signing off from the conference 🚆. A lot of learning points and things to consider for tomorrow’s practice, caught up with colleagues and formed new collaborations. Thank you @eular_org. Hope you enjoyed our @RheumNow coverage. See you in Berlin 🇩🇪 #EULAR2027 https://t.co/nyaBnHLrxr
Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )
Top tips: ⭐️ Summarise the key facts but always provide the source ⭐️ Learn from mistakes to improve what you have ⭐️ Have high quality source material- scan multiple resources for the best quality info and latest news! @RheumNow #EULAR2026

Mrinalini Dey @DrMiniDey( View Tweet )

A Field Whose Time Has Come: Launching the EULAR Study Group on Geriatric Rheumatology EULAR launches a Study Group on Geriatric Rheumatology — clinics increasingly serve older patients with multimorbidity, polypharmacy, frailty, cognitive and functional limits, yet research

Dr. John Cush @RheumNow( View Tweet )

×